297 related articles for article (PubMed ID: 89164)
1. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells.
Finberg R; Greene MI; Benacerraf B; Burakoff SJ
J Immunol; 1979 Sep; 123(3):1205-9. PubMed ID: 89164
[TBL] [Abstract][Full Text] [Related]
2. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cells.
Finberg R; Burakoff SJ; Benacerraf B; Greene MI
J Immunol; 1979 Sep; 123(3):1210-4. PubMed ID: 89165
[TBL] [Abstract][Full Text] [Related]
3. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
4. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
Sherman L; Mescher MF; Burakoff SJ
J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
[TBL] [Abstract][Full Text] [Related]
5. Non-H-2-associated genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. Effect on the magnitude of secondary response and helper T cell generation after in vivo priming.
Fujiwara H; Shearer GM
Eur J Immunol; 1981 Sep; 11(9):700-4. PubMed ID: 6975212
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of cell-mediated lympholysis to trinitrophenyl (TNP)-modified murine syngeneic cells. I. Expression of Ir gene function at the Cytotoxic precursor and helper cell levels in the response to TNP-H-2 b self.
Fujiwara H; Shearer GM
J Immunol; 1981 Mar; 126(3):1047-51. PubMed ID: 6780621
[No Abstract] [Full Text] [Related]
7. Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
Handa K; Herrmann S
J Immunol; 1985 Sep; 135(3):1564-72. PubMed ID: 2410495
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
Fujiwara H; Levy RB; Shearer GM
J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
[TBL] [Abstract][Full Text] [Related]
9. H2Kk can influence whether cytotoxic T lymphocytes recognize trinitrophenyl in association with H2Dk unique or H-2Kk and H-2Dk shared self determinants.
Fujiwara H; Tsuchida T; Levy RB; Shearer GM
J Immunol; 1982 Sep; 129(3):1189-93. PubMed ID: 6179996
[TBL] [Abstract][Full Text] [Related]
10. Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.
Wolos JA; Smith JB
J Immunol; 1981 Aug; 127(2):711-5. PubMed ID: 6454726
[TBL] [Abstract][Full Text] [Related]
11. Generation of H-2-restricted cytotoxic T cells by ultraviolet light-treated trinitrophenyl-modified syngeneic cells: increased requirement for adherent cells.
Hurme M; Bång BE; Sihvola M
J Immunol; 1980 Dec; 125(6):2484-8. PubMed ID: 6968785
[TBL] [Abstract][Full Text] [Related]
12. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self).
Arora PK; Hanna EE
Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952
[TBL] [Abstract][Full Text] [Related]
16. Decline, in aging mice, of the anti-2,4,6-trinitrophenyl (TNP) cytotoxic T cell response attributable to loss of Lyt-2-, interleukin 2-producing helper cell function.
Miller RA; Stutman O
Eur J Immunol; 1981 Oct; 11(10):751-6. PubMed ID: 6975716
[TBL] [Abstract][Full Text] [Related]
17. Helper cell analysis in cytotoxic T lymphocyte responses. I. Activation of specific and cross-reactive helper effects in two hapten-modified self responses.
Levy RB; Fujiwara H; Shearer GM
Eur J Immunol; 1980 Dec; 10(12):904-7. PubMed ID: 6162647
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
[TBL] [Abstract][Full Text] [Related]
19. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
20. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
